-
Product Insights
![]()
Likelihood of Approval Analysis for Hypersecretory Conditions
Overview How likely is it that the drugs in Hypersecretory Conditions will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Hypersecretory Conditions Overview Hypersecretory Condition is a group of disorders characterized by...
-
Product Insights
New![]()
Hypersecretory Conditions – Drugs In Development, 2024
Empower your strategies with our Hypersecretory Conditions – Drugs In Development, 2024 report and make more profitable business decisions. Hypersecretory Condition is a group of disorders characterized by hypersecretion of gastric acid also known as hypergastrinemia. This condition can result in peptic ulcers, GERD, gastrointestinal hemorrhage causing a predominant mortality and morbidity. Underlying diseases, helicobacter pylori infection, gastric outlet obstruction, chronic renal failure and idiopathic causes results to hypersecretion of gastric juice. Diagnosed by the gastrin levels and gastric acid secretion...
-
Product Insights
New![]()
Systemic Mastocytosis – Drugs In Development, 2024
Empower your strategies with our Systemic Mastocytosis – Drugs In Development, 2024 report and make more profitable business decisions. Systemic mastocytosis is a disorder where mast cells are abnormally increased in multiple organs including the bone marrow. Symptoms include shortness of breath, low blood pressure, hives and swelling, itching, diarrhea, headache, flushing, and musculoskeletal pain. Treatment includes antihistamines and more aggressive forms of medication, including interferon or chemotherapeutic agents. The Systemic Mastocytosis drugs in development market research report provide comprehensive information...
-
Product Insights
![]()
Net Present Value Model: Pariet/Aciphex
Overview Evaluating the value of drugs is a complicated practice and requires a deep knowledge of the drug itself, the market currently and in the future, knowledge of cash inflows and outflows and the potential success rates for each stage of drug development. GlobalData has done all of this work for you, leveraging its gold standard Drugs Intelligence database to create high-value NPV models for purchase on a drug-by-drug basis. Drug Operating Profit Model Pariet/Aciphex Drug Details Rabeprazole Sodium (Aciphex,...
-
Product Insights
![]()
Net Present Value Model: Pepcid
Overview Evaluating the value of drugs is a complicated practice and requires a deep knowledge of the drug itself, the market currently and in the future, knowledge of cash inflows and outflows and the potential success rates for each stage of drug development. GlobalData has done all of this work for you, leveraging its gold standard Drugs Intelligence database to create high-value NPV models for purchase on a drug-by-drug basis. Drug Operating Profit Model Pepcid Drug Details Famotidine (Pepcid, Pepcid...
-
Product Insights
![]()
Net Present Value Model: Losec / Prilosec
Overview Evaluating the value of drugs is a complicated practice and requires a deep knowledge of the drug itself, the market currently and in the future, knowledge of cash inflows and outflows and the potential success rates for each stage of drug development. GlobalData has done all of this work for you, leveraging its gold standard Drugs Intelligence database to create high-value NPV models for purchase on a drug-by-drug basis. Drug Operating Profit Model Losec / Prilosec Drug Details Omeprazole...
-
Product Insights
![]()
Net Present Value Model: Nexium
Overview Evaluating the value of drugs is a complicated practice and requires a deep knowledge of the drug itself, the market currently and in the future, knowledge of cash inflows and outflows and the potential success rates for each stage of drug development. GlobalData has done all of this work for you, leveraging its gold standard Drugs Intelligence database to create high-value NPV models for purchase on a drug-by-drug basis. Drug Operating Profit Model Nexium Drug Details Esomeprazole magnesium (Nexium,...
-
Product Insights
![]()
Net Present Value Model: Protonix
Overview Evaluating the value of drugs is a complicated practice and requires a deep knowledge of the drug itself, the market currently and in the future, knowledge of cash inflows and outflows and the potential success rates for each stage of drug development. GlobalData has done all of this work for you, leveraging its gold standard Drugs Intelligence database to create high-value NPV models for purchase on a drug-by-drug basis. Drug Operating Profit Model Protonix Drug Details Pantoprazole sodium (Zurcal...
Sign up to receive regular alerts for our latest analysis and reports. No matter your industry focus, you can keep your finger on the pulse with our timely updates.